Abstract
No public abstract is available from the verified source records.
Brian E Vestal, Beth Canono
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Prognostic accuracy of a peripheral blood transcriptome signature in chronic hypersensitivity pneumonitis
10.1136/thoraxjnl-2020-214790 · 2022
Single-cell analysis reveals novel immune perturbations in fibrotic hypersensitivity pneumonitis
10.1164/rccm.202401-0078oc · 2024
Diagnosis and evaluation of hypersensitivity pneumonitis: CHEST guideline and expert panel report
10.1016/j.chest.2021.03.066 · 2021
Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety
10.1136/thorax-2022-219795 · 2023
Prognostic impact of quantitative CT disease extent and pattern in fibrotic hypersensitivity pneumonitis
10.1093/annalsats/aaoag116 · 2026
The transcriptome of CD14(+)CD163(−)HLA-DR(low) monocytes predicts mortality in idiopathic pulmonary fibrosis
10.1183/13993003.00804-2025 · 2026
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
10.1186/s13059-014-0550-8 · 2014
eNetXplorer: an R package for the quantitative exploration of elastic net families for generalized linear models
10.1186/s12859-019-2778-5 · 2019
A blood and bronchoalveolar lavage protein signature of rapid FEV(1) decline in smoking-associated COPD
10.1038/s41598-023-32216-0 · 2023
Pathogenic variants screening in seventeen candidate genes on 2p15 for association with ankylosing spondylitis in a Han Chinese population
10.1371/journal.pone.0177080 · 2017
Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis
10.1152/ajpcell.00302.2023 · 2023
No additional external references are available.